Non-small cell lung cancer(NSCLC),miR-21,Autophagy,Proliferation,Apoptosis ,"/> <p class="MsoNormal" style="text-align:justify;"> Experimental study on the effect of miR-21 targeting Atg5 on the proliferation, migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy

Chinese Clinical Oncology ›› 2019, Vol. 24 ›› Issue (2): 97-101.

    Next Articles

Experimental study on the effect of miR-21 targeting Atg5 on the proliferation, migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy

  

  1. Department of Oncology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang 471003,China

  • Received:2018-09-05 Revised:2018-10-31 Accepted:2018-10-31 Online:2019-02-28 Published:2019-03-18

Abstract: Objective  To investigate the mechanism of miR-21 regulating autophagy of non-small cell lung cancer(NSCLC) by targeting autophagy-related target gene 5 (Atg5) and its role in proliferation, migration and invasion of A549 cells. Methods  Nonsense nucleic acid sequence NC (NC group), miR-21 mimics (miR-21 mimics group) and miR-21 inhibitor(miR-21 inhibitor group) were transfected into A549 cells, respectively. CCK-8 was used to detect the proliferation of A549 cells, scratch test was used to detect the migration ability of A549 cells, and Transwell invasion test was used to detect the invasion ability of A549 cells. Dual luciferase reporter gene assay verified the targeting relationship between miR-21 and Atg5. Western blotting was used to detect the expression of LC3B-II, p62 and Atg5 proteins. Results  Compared with NC group, the proliferation, migration and invasiveness of the cells in the miR-21 mimics group were up-regulated, while the proliferation, migration and invasiveness of the cells in the miR-21 inhibitor group were down-regulated (P<0.05). The results of double luciferase report experiment showed that miR-21 significantly inhibited the luciferase activity of wild-type Atg5 3’-UTR plasmid transfected cells (P<0.05), but had no effect on the luciferase activity after co-transfection of mutant Atg5 3’-UTR gene report plasmid with miR-21 mimics. The expression of LC3B-II protein in NC group was lower than that in miR-21 mimics group, higher than that in miR-21 inhibitor group (P<0.05); the expression of p62 and Atg5 protein in NC group was higher than that in miR-21 mimics group, lower than that in miR-21 inhibitor group  (P<0.05). Compared with NC group, 3-MA treatment decreased the proliferation of A549 cells induced by miR-21 mimics transfection (P<0.05). Scratch and Transwell experiments showed that 3-MA treatment inhibited the migration and invasion of A549 cells induced by miR-21 mimics transfection (P<0.05). Conclusion MiR-21 targeting Atg5 regulates autophagy in non-small cell lung cancer cells and promotes proliferation, migration and invasion of lung cancer cells.

Key words:

Non-small cell lung cancer(NSCLC)')">"> Non-small cell lung cancer(NSCLC), miR-21, Autophagy, Proliferation, Apoptosis

CLC Number: 

  • R734.2
[1] YE Lu, MU Dan, YANG Li, FU Bo, WANG Min..

Targeted inhibition of Rab27a by microRNA-582-5p on biological behavior of lung cancer cells [J]. Chinese Clinical Oncology, 2019, 24(2): 102-107.

[2] ZHANG Ning, LU Chuangxin, WU Sen, HE Yi, WEI Li. .

Expression and clinical significance of miRNA-138-5p in non-small cell lung cancer [J]. Chinese Clinical Oncology, 2019, 24(2): 149-152.

[3] GE Qin, QIAN Xia, XIE Guodong, CAI Jing, YANG Baixia, WU Jianting, ZHAO Jizhong, CUI Juanjuan, ZHU Xinghua, CHU Chunxia. . The effect of EGFR and TGF-α in radiosensitization of lung cancer cells [J]. Chinese Clinical Oncology, 2019, 24(2): 145-148.
[4] YANG Sanhu, WEN Miaomiao, ZHANG Zhipei, LI Weimiao, YANG Feng, LI Xiaofei..

Relationship of ROS1 fusion gene mutation with EGFR mutation and clinicopathological features in non-small cell lung cancer [J]. Chinese Clinical Oncology, 2019, 24(2): 175-178.

[5] QIN Boyu, SONG Qi, SUN Shengjie, SUN Qiong, TAO Ran, JIAO Shunchang. .

Progression of exosomes in non-small cell lung cancer drug resistance [J]. Chinese Clinical Oncology, 2019, 24(2): 179-182.

[6] WEI Danfeng, GUO Yuanbiao, WANG Zhanhao, ZHU Yifang..  The relationship between EGFR mutaion subtypes and the clinicopathological features of non-small cell lung cancer in Sichuan region [J]. Chinese Clinical Oncology, 2018, 23(10): 915-919.
[7] . [J]. Chinese Clinical Oncology, 2018, 23(10): 957-958.
[8] ZHANG Chao, NIU Yi, ZHANG Jie, YAO Xuemin, GAO Peng, LIU Meiyue, WEI Xiaomei, YANG Zhao, LIU Chunling, ZHANG Yueheng, LI Hongmin, SUN Guogui. .  

Effects of miR-1253 on proliferationmigration and invasion of lung adenocarcinoma cells [J]. Chinese Clinical Oncology, 2018, 23(10): 865-869.

[9] WANG Haitao, YANG Jingxian, SHUAI Shengsheng.. Effect of different working experience of radiation therapist on intensity modulated radiation therapy in elderly patients with stage Ⅲ non-small cell lung cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 449-452.
[10] . [J]. Chinese Clinical Oncology, 2018, 23(5): 476-478.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Chinese Clinical Oncology, 2009, 14(4): 361 .
[2] . [J]. Chinese Clinical Oncology, 2009, 14(4): 306 .
[3] . [J]. Chinese Clinical Oncology, 2009, 14(5): 466 .
[4] . [J]. Chinese Clinical Oncology, 2009, 14(5): 457 .
[5] . [J]. Chinese Clinical Oncology, 2009, 14(6): 505 .
[6] . [J]. Chinese Clinical Oncology, 2009, 14(7): 634 .
[7] . [J]. Chinese Clinical Oncology, 2009, 14(7): 628 .
[8] . [J]. Chinese Clinical Oncology, 2009, 14(8): 737 .
[9] . [J]. Chinese Clinical Oncology, 2009, 14(10): 912 .
[10] . [J]. Chinese Clinical Oncology, 2010, 15(5): 441 .